Author name: David Tuller

By David Tuller, DrPH On January 30th, Professor Racaniello e-mailed a letter of concern to Archives of Disease in Childhood about a clinical trial of the Lightning Process in children with CFS/ME (as the study called the illness.) The letter, signed by 21 experts and academics, documented the trial’s questionable methodological choices and the investigators’ …

Trial By Error: My Exchange With Archives of Disease in Childhood Read More »

By David Tuller, DrPH So I’ve been asked about my plans after June 30th, which is the end of the period covered by last year’s crowdfunding campaign. There’s been significant progress since I launched that effort. Among other developments, the CDC dropped its recommendations for CBT and GET, NICE decided to withdraw its preliminary reaffirmation …

Trial By Error: News About My Plans Read More »

By David Tuller, DrPH Last week, Professor Racaniello e-mailed a letter of concern signed by more than a dozen experts to Dr. Trish Groves, editor-in-chief of BMJ Open. The letter involved Professor Esther Crawley’s school absence study, which the journal published in 2011. As I’d documented in a post last year, the study exempted itself …

Trial By Error: Our Exchange of Views with BMJ Open Read More »

By David Tuller, DrPH Three weeks ago, Professor Racaniello e-mailed a letter of concern to Archives of Disease in Childhood about its recent study of the Lightning Process as a treatment for ME/CFS in kids. The journal’s editor, Dr. Nick Brown, answered within an hour, assuring Professor Racaniello that he took the matter seriously and …

Trial By Error: A Letter to BMJ Open Read More »

By David Tuller, DrPH Queen Mary University of London seems to have devised a fail-safe method of avoiding having to comply with more PACE-related freedom-of-information requests, just declare no one is around who can deal with it. Earlier this month, the U.K. Information Commissioner’s Office issued a decision in an appeal of QMUL’s rejection of …

Trial By Error: QMUL and FOI; Nature and Cochrane; the Pineapple Fund Read More »